Top Buy
| Security | Buy ▼ | Sell | Buy (1M) | Sell (1M) | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Neurocrine Bioscience | 29 | 0 | 6 | 0 | €127.60 | €140.60 | 10.191% |
| Iovance Biotherapeutics Inc. | 21 | 3 | 2 | 0 | €9.20 | €25.20 | 173.824% |
| United Therapeutics | 19 | 0 | 4 | 0 | €253.30 | €287.40 | 13.463% |
| Exelixis Inc. | 18 | 0 | 3 | 0 | €18.58 | €26.01 | 40.008% |
| Ultragenyx Pharmaceutical Inc. | 17 | 1 | 1 | 0 | €37.40 | €84.74 | 126.588% |
| PTC Therapeutics Inc. | 15 | 7 | 3 | 2 | €33.80 | €41.81 | 23.710% |
| Halozyme Therapeutics Inc. | 15 | 0 | 3 | 0 | €40.40 | €47.17 | 16.757% |
| Arrowhead Pharmaceuticals Inc. | 14 | 2 | 2 | 0 | €22.94 | €52.03 | 126.787% |
| Repligen Corp. | 13 | 0 | 1 | 0 | €144.45 | €184.76 | 27.906% |
| Charles River Labs Intl | 10 | 0 | 1 | 0 | €200.40 | €248.57 | 24.037% |
| Xencor Inc. | 10 | 1 | 1 | 0 | €21.60 | €32.58 | 50.828% |
| Medpace Holdings Inc | 9 | 0 | 0 | 0 | €361.20 | €421.61 | 16.723% |
| Agios Pharmaceuticals Inc. | 6 | 0 | 1 | 0 | €31.40 | €38.99 | 24.168% |
| Nektar Therapeutics | 3 | 1 | 0 | 0 | €1.51 | €3.70 | 145.033% |
| Emergent Biosolutions Inc. | 2 | 3 | 0 | 0 | €4.50 | €4.62 | 2.577% |
| Blueprint Medicines Corp | 2 | 0 | 1 | 0 | €93.68 | - | - |
| Novocure Ltd | 1 | 1 | 0 | 0 | €21.36 | - | - |
| Catalent Inc. | 1 | 0 | 0 | 0 | €50.37 | €55.00 | 9.192% |